SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001168220-14-000007
Filing Date
2014-02-05
Accepted
2014-02-05 16:15:19
Documents
5

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/AMENDMENT #4 - IPMD 02/05/2014 sc13da-ipmd_020514.htm SC 13D/A 69357
2 ASSIGNMENT AGREEMENT, DATED JANUARY 31, 2014 ex_99-1.htm EX-99.1 124569
3 IMPLEMENTATION AGREEMENT, DATED JANUARY 31, 2014 ex_99-2.htm EX-99.2 103112
4 STOCKHOLDERS' AGREEMENT, DATED JANUARY 31, 2014 ex_99-3.htm EX-99.3 119327
5 EQUALIZATION AGREEMENT, DATED JANAURY 31, 2014 ex_99-4.htm EX-99.4 91440
  Complete submission text file 0001168220-14-000007.txt   509378
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Subject) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79412 | Film No.: 14576350
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ULURU INC. 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address SCHREYVOGELGASSE 3/5 VIENNA C4 1010AT 214-505-5145
IPMD GmbH (Filed by) CIK: 0001567515 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A